+ Resolve Article
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter

+ Translate
+ Subscribe to Site Feed
GeoScience Most Shared ContentMost Shared Content

Niacin reduces plasma CETP levels by diminishing liver macrophage content in CETP transgenic mice

, : Niacin reduces plasma CETP levels by diminishing liver macrophage content in CETP transgenic mice. Biochemical Pharmacology 84(6): 821-829

The anti-dyslipidemic drug niacin has recently been shown to reduce the hepatic expression and plasma levels of CETP. Since liver macrophages contribute to hepatic CETP expression, we investigated the role of macrophages in the CETP-lowering effect of niacin in mice. In vitro studies showed that niacin does not directly attenuate CETP expression in macrophages. Treatment of normolipidemic human CETP transgenic mice, fed a Western-type diet with niacin for 4 weeks, significantly reduced the hepatic cholesterol concentration (-20%), hepatic CETP gene expression (-20%), and plasma CETP mass (-30%). Concomitantly, niacin decreased the hepatic expression of CD68 (-44%) and ABCG1 (-32%), both of which are specific markers for the hepatic macrophage content. The decrease in hepatic CETP expression was significantly correlated with the reduction of hepatic macrophage markers. Furthermore, niacin attenuated atherogenic diet-induced inflammation in liver, as evident from decreased expression of TNF-alpha (-43%). Niacin similarly decreased the macrophage markers and absolute macrophage content in hyperlipidemic APOE*3-Leiden.CETP transgenic mice on a Western-type diet. In conclusion, niacin decreases hepatic CETP expression and plasma CETP mass by attenuating liver inflammation and macrophage content in response to its primary lipid-lowering effect, rather than by attenuating the macrophage CETP expression level.


PMID: 22750059

DOI: 10.1016/j.bcp.2012.06.020

Other references

Penny, A.R., 1956: Jumpers down and up. Medical Technicians Bulletin 7(4): 139-141

Higashida, A.; Hoashi, T.; Sakaguchi, H.; Ichikawa, H., 2017: Neonatal repair of left atrial diverticulum with gigantic thrombus without cardiopulmonary bypass. A 5-day-old neonate with coarctation of the aorta, hypoplastic aortic arch, large apical muscular ventricular septal defect, and patent ductus arteriosus developed pulmonary over-circulation and systemic hypoperfusion underwent bilateral pulmonary...

Kobayashi T.M.Y.mamoto; Mcghee, J.R.; Takeshita, Y.; Kiyono, H., 1994: The effect of defined liquid elemental diet fortified with arginine on mucosally induced immune responses. FASEB Journal 8(4-5): A515

Pollitt, B., 2004: Fool's gold: psychologists using disingenuous reasoning to mislead legislatures into granting psychologists prescriptive authority. American Journal of Law & Medicine 29(4): 489-524

Liew C.T.; Mcquire L.; Lee J.C.K.; Arnold M., 1991: Ln1 igm monoclonal antibody as a specific membranous marker for hepatocellular carcinoma. Hepatology 14(4 PART 2): 177A

Muresu, E.; Piana, A.; Azara, A.; Maida, I.; Nastasi, A.; Sajid, S.D.; Rubino, S., 2001: Clonal relations among Salmonella enteritidis phage type 3 outbreak isolates traced by DNA fingerprinting. Isolates of Salmonella enteritidis PT3, a rare phage type, were recovered from patients and strains were isolated from an outbreak of gastroenteritis that occurred during the summer of 1997 in North-East Sardinia, Italy. To investigate possible cl...

Catara; Piccitto; Sambataro; Van Giai N, 1996: Towards a self-consistent random-phase approximation for Fermi systems. Physical Review. B, Condensed Matter 54(24): 17536-17546

Moguilevsky, L., 1957: Extended interscapular thoracicomammary disarticulation. Boletines Y Trabajos - Sociedad de Cirugia de Buenos Aires 41(19): 559-65; Discussion 565-73

Martinson, E.J., 1965: Malignant Ovarian Teratoma In A Nine-Year-Old Girl. Minnesota Medicine 48: 1175-1177

He, X.S.u; D.C.sta, B.; Wasley, J.W.F., 2000: 1- aminoisoquinolines; a new class of dopamine receptor subtype specific ligands. Disclosed are compounds of the formula ##STR1## or the pharmaceutically acceptable salts thereof wherein the 6-membered A ring may be optionally substituted with up to four groups independently selected from halogen, hydroxy, lower alkyl, or lower...